Gibson, Dunn & Crutcher's health care practice in Washington will get a boost with the addition of a new attorney from the Food and Drug Administration's Office of Chief Counsel.
Steven Tave has joined the firm as of counsel and will focus his practice on FDA compliance, litigation and enforcement. He served as the FDA's associate chief counsel for enforcement.
By phone Tuesday, Tave said he will draw on his six years of federal prosecution work when advising his clients, which will be split primarily between pharmaceutical and medical device manufacturers. He said he expects the "trend in recent years where a lot of the enforcement has been focused on drug companies" to begin to include more actions against medical device manufacturers as Washington ratchets up scrutiny of the health care industry.
"The amount of resources they're devoting to these kinds of cases is increasing every year," Tave said, refering to increased actions by the Justice Department and the FDA. In particular, he said the promotion of pharmaceuticals and the manufacturing of medical devices are areas he expects to draw regulators' attention.
Mark Perry, co-chair of Gibson Dunn's life sciences practice, said in a statement that Tave will be a "key player" in the development of the FDA compliance and enforcement practice started in December with the addition of Steve Payne from Sidley Austin.